Michael King

Affiliations

  • Chief Financial Officer at Sab Biotherapeutics Inc. (SABS), 2024-02-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SABS $0.90 5,000 5,000 2023-11-30 Filing